Brief: Kintor Pharmaceutical Says KT International Investment Agreed To Sell 34.1 Million Shares In Aggregate
Aug 31 (Reuters) - Kintor Pharmaceutical 9939.HK :
* KT INTERNATIONAL INVESTMENT AGREED TO SELL 34.1 MILLION
SHARES
IN AGGREGATE HELD BY IT
* NET PROCEEDS FROM SUBSCRIPTION ARE ESTIMATED TO BE
HK$347.5
MILLION
* INTENDS TO USE NET PROCEEDS FROM SUBSCRIPTION FOR CLINICAL
DEVELOPMENT AND COMMERCIALISATION OF PRUXELUTAMIDE, AMONG OTHERS
Source text for Eikon: ID:nHKS6sRD4
Further company coverage: 9939.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kintor Pharmaceutical
See all newsBrief: Kintor Pharmaceutical Receives Invention Patent Grant For KT-939 In China
Brief: Kintor Pharmaceutical Says Ming Ming Cheung Resigns As CFO
Brief: Kintor Pharmaceutical Says CEO Via Wholly Owned Co Increases Shareholding By 2.51 Million Shares
Brief: Kintor Pharmaceutical Says YTD 2026 Sales Revenue At RMB34 Million
Brief: Kintor Pharmaceutical Says Pharma's Kx-826 Phase Iii Trial In China Reaches Primary Endpoint